Friday, May 8, 2009           
  • IVIG Supply Index
  • Albumin Supply Index
  • Open Market Pricing
  • Reimbursement Rates
  • FFF News
  • Industry News
  • Subscribe to IG Living
  • MyFluVaccine Orders
  • Resources
Hyperimmune
Immune Globulin
Factor
Injectable Influenza

Decision on Flu Vaccine Looms

WASHINGTON — The Obama administration is weeks away from a critical decision on whether to trigger mass production of swine-flu vaccine, which could affect the bottom lines of big vaccine makers as well as public health.

Besides determining whether a vaccine would be effective and safe, government officials and private laboratories will need to answer practical and financial questions: Does it make sense to... more »

Swine Flu, Part II: What's in Store in the Months to Come

CNN — With mostly mild cases of swine flu in the United States, swine flu fears are lessening. But viruses have a way of re-appearing. While nobody has a crystal ball, here are some thoughts about what the 2009 H1N1 virus might do in the months to come. ... more »

 
   
 
IVIG Supply Index represents FFF's aggregate inventory of all IVIG products for all our customers who have established product allocations with us (not individual or group allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more. Albumin Supply Index represents FFF's aggregate i nventory of Albumin for all our customers who have established product allocations with us (not individual or group allocations). Blue represents 21 days supply or less, purple is 22 to 29 days, green is 30 days supply or more

FFF Enterprises is pleased to announce the July debut of our new publication — BioSupply Trends Quarterly (BSTQ). BSTQ will provide you with timely and in-depth marketplace information and will serve as a complement to our award-winning BioSupply Trends e-newsletter.

BSTQ's themed issues will cover topics ranging from product development, industry insights and innovations, up-to-the-minute news on the latest clinical trials, accessibility, and service and safety concerns. Readers will also find informative columns, research updates, product news, a valuable resource guide and a pull-out product catalog and reference guide.

As we share our knowledge, challenges and insights, we can partner together to create innovative solutions to meet marketplace demands and the needs of our customers. Look for your first issue in July!


From Reuters

Scheduling Problems Lead to Missed Immunizations more »

From American Enterprise Institute for Public Policy Research
Bad Medicine in the Market
Counterfeit medicines are an insidious threat to global health, and the risks they pose have been largely underestimated to date. more »

From sanofi pasteur
U.S. FDA Licenses Sanofi Pasteur's New Influenza Vaccine Manufacturing Facility more »

 
Physician's Office Reimbursement Rates
Carimune:
$62.036/gm

Flebogamma injection
$71.234/gm
Gammagard liquid injection:
$70.158/gm
Gammagard SD:
$62.036/gm

Gamunex injection:
$72.406/gm

Octagam injection:
$73.572/gm

Privigen:
$70.378/gm
Effective April 1, 2009
through June 30, 2009

 
   
   
     
 
Home | About Us | Contact   ©2009 FFF Enterprises, Inc.